| Nanobody-based CAR-T cells for cancer immunotherapy P Safarzadeh Kozani, A Naseri, SMJ Mirarefin, F Salem, M Nikbakht, ... Biomarker research 10 (1), 24, 2022 | 96 | 2022 |
| Recent advances in solid tumor CAR-T cell therapy: driving tumor cells from hero to zero? P Safarzadeh Kozani, P Safarzadeh Kozani, M Ahmadi Najafabadi, ... Frontiers in Immunology 13, 795164, 2022 | 43 | 2022 |
| CAR-T cell therapy in triple-negative breast cancer: Hunting the invisible devil F Nasiri, M Kazemi, SMJ Mirarefin, M Mahboubi Kancha, ... Frontiers in Immunology 13, 1018786, 2022 | 42 | 2022 |
| Insights into organoid-based modeling of COVID-19 pathology MH Boroojerdi, T Al Jabry, SMJ Mirarefin, H Albalushi Virology Journal 20 (1), 37, 2023 | 7 | 2023 |
| The epigenetic contribution to the pathogenesis of psoriasis: recent advances S Aslani, SMJ Mirarefin, H Zarredar, M Asadi, MR Javan, A Khosrojerdi, ... Current Medicinal Chemistry 31 (29), 4621-4639, 2024 | 3 | 2024 |
| COVID-19 Vaccines in Iran PS Kozani, PS Kozani, SMJ Mirarefin, S Sheikhi, N Baharifar, M Sheikhi, ... Trends in Medical Sciences 2 (2), 2022 | 3 | 2022 |
| ACE2 in SARS-CoV-2-Mediated COVID-19: A Brief Review PS Kozani, SD Shokoohi, N Baharifar, S Sheikhi, FK Shamsabadi, ... Trends in Medical Sciences 2 (4), 2022 | 1 | 2022 |
| Bebtelovimab: the FDA-approved monoclonal antibody for treating patients with mild-to-moderate COVID-19 PS Kozani, M Sheikhi, N Baharifar, SD Shokoohi, S Sheikhi, ... Trends in Medical Sciences 2 (3), 2022 | 1 | 2022 |
| Mesenchymal stem cell application in pulmonary disease treatment with emphasis on their interaction with lung-resident immune cells A Hazrati, SMJ Mirarefin, K Malekpour, A Rahimi, A Khosrojerdi, ... Frontiers in Immunology 15, 1469696, 2024 | | 2024 |
| COVID-19 Treatment and Management: Two Years After the Outbreak PS Kozani, PS Kozani, N Baharifar, M Sheikhi, F Kiani, FC Nejad, ... Trends in Medical Sciences 2 (2), 2022 | | 2022 |
| Conjugation of a Podoplanin-specific Single-chain Fragment Variable (scFv) to Granzyme B for Designing a Potential Therapeutic Against Malignant Tumors: An In-silico Experiment SMJ Mirarefin Archives of Advances in Biosciences 15 (1), 0 | | |
